ImmunoCellular Therapeutics, Ltd. News Headlines

IMUC 
$0.7151
*  
0.022
2.98%
Get IMUC Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading IMUC now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    IMUC Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
ImmunoCellular Therapeutics To Present In Livingston Conference At 1:55 PM ET
10/1/2014 12:55:00 PM - RTT News


ImmunoCellular Establishes Licensing Agreement With Caltech - Quick Facts
9/24/2014 6:06:00 AM - RTT News


ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape
9/18/2014 9:58:00 AM - Zacks.com


ImmunoCellular: Thoughts On Management's Plan To Move ICT-107 Into Phase 3
9/9/2014 10:18:00 AM - Seeking Alpha


Wednesday Sector Laggards: Drugs, Biotechnology Stocks
7/16/2014 3:35:27 PM - BNK Invest


Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer
7/15/2014 2:40:00 PM - Seeking Alpha


Positive Trends For ImmunoCellular Therapeutics
6/9/2014 10:57:00 AM - Seeking Alpha


Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
6/6/2014 1:45:00 PM - Seeking Alpha


Monday Sector Laggards: Drugs, Manufacturing Stocks
6/2/2014 3:44:31 PM - BNK Invest


ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 11:41:00 AM - Seeking Alpha


ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 10:41:45 AM - SeekingAlpha


ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 10:41:00 AM - Seeking Alpha


Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunotherapeutic Vaccine
6/2/2014 8:56:05 AM - MT Newswires


Sector Update: Healthcare
6/2/2014 8:55:31 AM - MT Newswires


ImmunoCellular Therapeutics: Potential Near-Term Upward Spike
5/20/2014 10:24:00 AM - Seeking Alpha


Refuting The Latest Negative Blog On Northwest Biotherapeutics
4/3/2014 3:50:00 PM - Seeking Alpha


ImmunoCellular: Is Approval Enough?
2/24/2014 10:48:00 AM - Seeking Alpha


Northwest Is A Good Long-Term Bet
2/14/2014 10:57:00 AM - Seeking Alpha


Focus On Cancer Immunotherapy Results
1/25/2014 3:41:00 AM - Seeking Alpha


My 2014 Diversified REIT Portfolio Designed For Outperformance
1/7/2014 1:56:00 AM - Seeking Alpha


Dendritic Cell Vaccines: A Look Back At Clinical Trials Since 1999
1/2/2014 11:46:00 AM - Seeking Alpha


Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
1/2/2014 8:58:00 AM - Seeking Alpha


Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
12/20/2013 11:30:00 AM - Seeking Alpha


Immunocellular Shares Are Set For A Rebound
12/20/2013 6:54:00 AM - Seeking Alpha


Celldex: Some Thoughts On Rindopepimut
12/19/2013 12:43:00 PM - SeekingAlpha